<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mpath ids='MPATH_271'>Adenomatous polyposis coli</z:mpath> (APC) is best known for its crucial role in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> suppression </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">Rodent models</z:e> with various Apc mutations have enabled experimental validation of different Apc functions in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="2" pm="."><plain>Since the development of the first mouse model with a germline Apc mutation in the early 1990s, 20 other Apc mouse and rat models have been generated </plain></SENT>
<SENT sid="3" pm="."><plain>This article compares and contrasts currently available Apc <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent models</z:e> with particular emphasis on providing potential explanations for their reported variation in three areas: (i) intestinal <z:mpath ids='MPATH_491'>polyp</z:mpath> multiplicity, (ii) intestinal <z:mpath ids='MPATH_491'>polyp</z:mpath> distribution, and (iii) extraintestinal phenotypes </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Res; 73(8); 1-11. Â©2013 AACR </plain></SENT>
</text></document>